A comparative study of action of atracurium vs action of vecuronium in general anesthesia
试验速览
- 阶段
- 1 期
- 状态
- 尚未招募
- 发起方
- 入组人数
- 80
- 试验地点
- 1
- 主要终点
- To explore the dose-response relationship
研究概览
简要总结
Atracurium and vecuronium are both non-depolarizing neuromuscular blocking agents used in general anesthesia to facilitate intubation and surgery.
Onset and Duration of Action: Both drugs have a rapid, dose-dependent onset (1-4 minutes) and a duration of action one-third to one-half that of pancuronium. Atracurium generally has a shorter duration compared to vecuronium, making it preferable in cases requiring a brief muscle relaxation period.
Metabolism: Atracurium undergoes spontaneous chemical degradation, while vecuronium is primarily metabolized by the liver. This difference in metabolism makes vecuronium more suitable for patients with normal liver function, whereas atracurium may be a better choice in cases of liver or kidney dysfunction.
Clearance: Both agents have a plasma clearance rate of about 5 ml/min/kg, which is faster than many longer-acting agents, leading to rapid recovery and minimal accumulation with repeated doses.
In conclusion, the choice between atracurium and vecuronium depends on factors like the desired duration of action, patient liver and kidney function, and specific surgical needs, allowing anesthesiologists to optimize patient care
研究设计
- 研究类型
- Interventional
- 分配方式
- Other
- 盲法
- None
入排标准
- 年龄范围
- 18.00 Year(s) 至 65.00 Year(s)(—)
- 性别
- All
入选标准
- •American Society of Anesthesiologists (ASA) physical status classification I or II Patients who provide informed consent for participation.
排除标准
- •patient over 90 kg.
- •Pregnant or breastfeeding women.
- •a history of renal, hepatic or neuromuscular disease, asthma, hypersensitivity to anaesthetic agents.
- •ASA 3 or above.
结局指标
主要结局
To explore the dose-response relationship
时间窗: Every 3 min for 15 min then every 15 min till | recovery
between atracurium and vecuronium during general anaesthesia
时间窗: Every 3 min for 15 min then every 15 min till | recovery
次要结局
- To identify any potential predictors of optimal(dose selection of atricurium and rocuronium based on)
研究者
Dr Babneet singh kalra
Varun Arjun Medical College and Rohilkhand Hospital
